Suchergebnisse - "O3J8G9O825"

PubPharm (578)

91

Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients

enthalten in: Clinical pharmacokinetics | 2013

von Moltó, J. | Xinarianos, G. | Miranda, C. | +5

92

Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals : a prospective, multicenter study

enthalten in: BMC infectious diseases | 2013

von Cao, Y. | Han, Y. | Xie, J. | +7

93

Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial

enthalten in: Antimicrobial agents and chemotherapy | 2013

von Parienti, J. | Barrail-Tran, A. | Duval, X. | +8

94

Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2013

von Cespedes, M. | Castor, D. | Ford, S. | +4

95

Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response : results of a randomized multicenter trial (ANRS 130 Apollo)

enthalten in: Antimicrobial agents and chemotherapy | 2013

von Joly, V. | Fagard, C. | Grondin, C. | +110

96

Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents : ritonavir-boosted atazanavir, efavirenz and tenofovir

enthalten in: Antiviral therapy | 2013

von Bifano, M. | Hwang, C. | Oosterhuis, B. | +7

97

Effect of efavirenz, nevirapine, etravirine, and raltegravir administration on the pharmacokinetics of ritonavir-boosted darunavir in a population of HIV-infected patients

enthalten in: AIDS research and human retroviruses | 2013

von Dailly, E. | Allavena, C. | Bouquié, R. | +3

98

Pharmacokinetics of rifabutin in Japanese HIV-infected patients with or without antiretroviral therapy

enthalten in: PloS one | 2013

von Tanuma, J. | Sano, K. | Teruya, K. | +8

99

Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1

enthalten in: Journal of medical virology | 2013

von Ghosn, J. | Slama, L. | Chermak, A. | +44

100

Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children : comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir

enthalten in: The Journal of antimicrobial chemotherapy | 2012

von Chokephaibulkit, K. | Nuntarukchaikul, M. | Phongsamart, W. | +4